Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205777 · ClinicalTrials.gov registry record · Phase 3
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 7,609
- Enrollment target
NCT00205777 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 7,609 participants.
The verdict
NCT00205777, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 7,609 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.
Interventions
- OTHER Placebo
- DRUG Bazedoxifene Acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,609 participants |
| Start Date | 2001-12 |
| Est. Completion | 2010-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00205777
The ClinicalTrials.gov registry entry for NCT00205777 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 7,609 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00205777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00205777 about?
NCT00205777 is a clinical study titled "Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women". The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.
What is the current status of trial NCT00205777?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 7,609 participants. The study started on 2001-12. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00205777?
The interventions under investigation include: Placebo (OTHER), Bazedoxifene Acetate (DRUG).
Who is sponsoring clinical trial NCT00205777?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.